Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systemic Treatment of Pediatric Psoriasis: A Review
Maddalena Napolitano, Matteo Megna, Anna Balato, et al.
Dermatology and Therapy (2016) Vol. 6, Iss. 2, pp. 125-142
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist
Luigi Barrea, Maria Cristina Savanelli, Carolina Di Somma, et al.
Reviews in Endocrine and Metabolic Disorders (2017) Vol. 18, Iss. 2, pp. 195-205
Open Access | Times Cited: 226
An update on generalized pustular psoriasis
Melinda Gooderham, Abby S. Van Voorhees, Mark Lebwohl
Expert Review of Clinical Immunology (2019) Vol. 15, Iss. 9, pp. 907-919
Open Access | Times Cited: 193
Controversies in Vitamin D: A Statement From the Third International Conference
Andrea Giustina, Roger Bouillon, Neil Binkley, et al.
JBMR Plus (2020) Vol. 4, Iss. 12
Open Access | Times Cited: 156
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients
Matteo Megna, Elisa Camela, Teresa Battista, et al.
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 1, pp. 25-41
Closed Access | Times Cited: 42
Systemic Treatment of Adult Atopic Dermatitis: A Review
Matteo Megna, Maddalena Napolitano, Cataldo Patruno, et al.
Dermatology and Therapy (2016) Vol. 7, Iss. 1, pp. 1-23
Open Access | Times Cited: 139
Langerhans cell histiocytosis in children
Jolie Krooks, Milen Minkov, Angela Weatherall
Journal of the American Academy of Dermatology (2018) Vol. 78, Iss. 6, pp. 1047-1056
Closed Access | Times Cited: 113
Efficacy and safety of ixekizumab in a phase III , randomized, double‐blind, placebo‐controlled study in paediatric patients with moderate‐to‐severe plaque psoriasis ( IXORA ‐ PEDS )
Amy S. Paller, Marieke M.B. Seyger, Gabriel A. Magariños, et al.
British Journal of Dermatology (2020) Vol. 183, Iss. 2, pp. 231-241
Open Access | Times Cited: 91
Biologics‐Loaded Photothermally Dissolvable Hyaluronic Acid Microneedle Patch for Psoriasis Treatment
Dan Wu, Xin Shou, Yunru Yu, et al.
Advanced Functional Materials (2022) Vol. 32, Iss. 47
Closed Access | Times Cited: 44
A phase 3 open-label, randomized multicenter study to evaluate efficacy and safety of secukinumab in pediatric patients with moderate to severe plaque psoriasis: 24-week results
Nina Magnolo, Külli Kingo, Vivian Laquer, et al.
Journal of the American Academy of Dermatology (2021) Vol. 86, Iss. 1, pp. 122-130
Closed Access | Times Cited: 36
Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis
Amy S. Paller, Marieke M.B. Seyger, Gabriel A. Magariños, et al.
JAMA Dermatology (2022) Vol. 158, Iss. 5, pp. 533-533
Open Access | Times Cited: 26
S2k guidelines for the treatment of psoriasis in children and adolescents – Short version part 2
Lisa Eisert, Matthias Augustin, Sabine Bach, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2019) Vol. 17, Iss. 9, pp. 959-973
Closed Access | Times Cited: 37
Pediatric Psoriasis: From New Insights into Pathogenesis to Updates on Treatment
Hye One Kim, Seok Young Kang, Jin Cheol Kim, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 940-940
Open Access | Times Cited: 27
Update on the Management of Pediatric Psoriasis: An Italian Consensus
Ketty Peris, Anna Belloni Fortina, Luca Bianchi, et al.
Dermatology and Therapy (2022) Vol. 12, Iss. 8, pp. 1753-1775
Open Access | Times Cited: 19
Metformin inhibits pro‐inflammatory responses via targeting nuclear factor‐κB in HaCaT cells
Wei Ba, Yuanyuan Xu, Guang Yin, et al.
Cell Biochemistry and Function (2018) Vol. 37, Iss. 1, pp. 4-10
Closed Access | Times Cited: 35
Sustained long‐term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double‐blind, phase III study
Diamant Thaçi, Kim Papp, Danielle Marcoux, et al.
British Journal of Dermatology (2019) Vol. 181, Iss. 6, pp. 1177-1189
Open Access | Times Cited: 34
Treatment Strategies for Psoriasis using Flavonoids from Traditional Chinese Medicine
Akash Gupta, Parag Jain, Kushagra Nagori, et al.
Pharmacological Research - Modern Chinese Medicine (2024) Vol. 12, pp. 100463-100463
Open Access | Times Cited: 3
Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
Robin C. Yi, Shannon Moran, Hannah Y. Gantz, et al.
Children (2024) Vol. 11, Iss. 8, pp. 892-892
Open Access | Times Cited: 3
Managing pediatric psoriasis: update on treatments and challenges—a review
Adelaide A. Hebert, John Browning, P. C. Kwong, et al.
Journal of Dermatological Treatment (2022) Vol. 33, Iss. 5, pp. 2433-2442
Open Access | Times Cited: 14
Biologics in pediatric psoriasis – efficacy and safety
Sunil Dogra, Rahul Mahajan
Expert Opinion on Drug Safety (2017) Vol. 17, Iss. 1, pp. 9-16
Closed Access | Times Cited: 26
An Overview of Contemporary and Future Therapeutic Strategies for Scalp Psoriasis
B. K. Soni, Riya Shivgotra, Karan Trehan, et al.
Current Drug Targets (2024) Vol. 25, Iss. 5, pp. 353-373
Closed Access | Times Cited: 2
Calcipotriene betamethasone dipropionate aerosol foam in the treatment of plaque psoriasis: a review of the literature
Jillian Frieder, Darío Kivelevitch, Alan Menter
Therapeutic Delivery (2017) Vol. 8, Iss. 9, pp. 737-746
Closed Access | Times Cited: 20
Update in the management of pediatric psoriasis
Jennifer Aileen Tangtatco, Irene Lara‐Corrales
Current Opinion in Pediatrics (2017) Vol. 29, Iss. 4, pp. 434-442
Closed Access | Times Cited: 17
Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study
Maddalena Napolitano, Luisa Costa, Francesco Caso, et al.
Clinical Rheumatology (2017) Vol. 36, Iss. 7, pp. 1589-1593
Closed Access | Times Cited: 16
Long-term remission induced by secukinumab in a 13-year-old boy having recalcitrant chronic erythrodermic psoriasis
Sunil Dogra, Anuradha Bishnoi, Tarun Narang, et al.
Dermatologic Therapy (2018) Vol. 31, Iss. 4, pp. e12611-e12611
Open Access | Times Cited: 16
Latin American Clinical Practice Guidelines on the Systemic Treatment of Psoriasis SOLAPSO – Sociedad Latinoamericana de Psoriasis (Latin American Psoriasis Society)
Nora Kogan, Nélida Raimondo, Simón Gusis, et al.
International Journal of Dermatology (2019) Vol. 58, Iss. S1, pp. 4-28
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top